| Primary |
| Product Used For Unknown Indication |
26.1% |
| Depression |
17.4% |
| Parkinson's Disease |
17.4% |
| Hiv Infection |
13.0% |
| Generalised Anxiety Disorder |
8.7% |
| Hypertension |
8.7% |
| Arrhythmia |
4.3% |
| Hypothyroidism |
4.3% |
|
| Dyskinesia |
14.3% |
| Haematospermia |
14.3% |
| Hyponatraemia |
14.3% |
| Myalgia |
14.3% |
| Prothrombin Time Prolonged |
14.3% |
| Sensory Loss |
14.3% |
| Vomiting |
14.3% |
|
| Secondary |
| Product Used For Unknown Indication |
45.4% |
| Schizophrenia |
10.7% |
| Depression |
9.2% |
| Psychotic Disorder |
8.0% |
| Drug Use For Unknown Indication |
7.5% |
| Hypertension |
4.5% |
| Bipolar I Disorder |
4.2% |
| Anxiety |
1.4% |
| Hiv Infection |
1.3% |
| Neck Pain |
1.3% |
| Hypercholesterolaemia |
0.8% |
| Insomnia |
0.8% |
| Diabetes Mellitus |
0.7% |
| Type 2 Diabetes Mellitus |
0.7% |
| Thrombosis Prophylaxis |
0.6% |
| Bipolar Disorder |
0.6% |
| Dementia Alzheimer's Type |
0.6% |
| Hypothyroidism |
0.6% |
| Pain |
0.6% |
| Prophylaxis |
0.6% |
|
| Hepatitis Cholestatic |
9.2% |
| Hyponatraemia |
7.8% |
| Toxic Epidermal Necrolysis |
7.8% |
| Vomiting |
7.8% |
| Malaise |
7.1% |
| Orthostatic Hypotension |
7.1% |
| Thrombocytopenia |
7.1% |
| Fall |
4.3% |
| Premature Baby |
4.3% |
| Rhabdomyolysis |
4.3% |
| Somnolence |
4.3% |
| Suicide Attempt |
4.3% |
| Toxicity To Various Agents |
4.3% |
| Wound |
4.3% |
| Hepatitis |
3.5% |
| Cataract |
2.8% |
| Hypotension |
2.8% |
| Pruritus |
2.8% |
| Hepatic Fibrosis |
2.1% |
| Inappropriate Antidiuretic Hormone Secretion |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.2% |
| Drug Use For Unknown Indication |
17.2% |
| Depression |
11.3% |
| Hypertension |
6.6% |
| Hepatitis C |
5.3% |
| Hiv Infection |
5.0% |
| Anxiety |
4.5% |
| Pain |
3.3% |
| Insomnia |
2.7% |
| Schizophrenia |
2.2% |
| Prophylaxis |
2.1% |
| Bipolar Disorder |
1.8% |
| Rheumatoid Arthritis |
1.5% |
| Epilepsy |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Breast Cancer |
1.3% |
| Osteoporosis |
1.2% |
| Diabetes Mellitus |
1.1% |
| Acute Myeloid Leukaemia |
1.0% |
| Atrial Fibrillation |
1.0% |
|
| Renal Failure |
9.9% |
| Renal Failure Acute |
9.9% |
| Vomiting |
9.9% |
| Thrombocytopenia |
8.9% |
| Neutropenia |
5.4% |
| Pulmonary Embolism |
5.0% |
| Hepatocellular Injury |
4.5% |
| Somnolence |
4.5% |
| Weight Decreased |
4.5% |
| Weight Increased |
4.5% |
| Rhabdomyolysis |
4.0% |
| Thrombophlebitis |
4.0% |
| Toxic Skin Eruption |
4.0% |
| Urticaria |
3.5% |
| Lung Disorder |
3.0% |
| Overdose |
3.0% |
| Pyrexia |
3.0% |
| Respiratory Distress |
3.0% |
| Tremor |
3.0% |
| Urinary Retention |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
26.3% |
| Depression |
19.4% |
| Atrial Fibrillation |
8.6% |
| Arrhythmia |
5.1% |
| Hypertension |
5.1% |
| Asthma |
3.4% |
| Musculoskeletal Pain |
3.4% |
| Back Pain |
2.9% |
| Insomnia |
2.9% |
| Thrombosis Prophylaxis |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Hiv Infection |
2.3% |
| Osteoarthritis |
2.3% |
| Product Used For Unknown Indication |
2.3% |
| Alcohol Detoxification |
1.7% |
| Hiatus Hernia |
1.7% |
| Hypothyroidism |
1.7% |
| Pain |
1.7% |
| Angina Pectoris |
1.1% |
|
| International Normalised Ratio Increased |
22.9% |
| Drug Interaction |
11.4% |
| Hypothermia |
8.6% |
| Rectal Haemorrhage |
8.6% |
| Ischaemic Stroke |
5.7% |
| Pneumonia Aspiration |
5.7% |
| Epilepsy |
2.9% |
| Gastrointestinal Haemorrhage |
2.9% |
| Hyponatraemia |
2.9% |
| Inappropriate Antidiuretic Hormone Secretion |
2.9% |
| Labelled Drug-drug Interaction Medication Error |
2.9% |
| Neuropathy Peripheral |
2.9% |
| Overdose |
2.9% |
| Shock |
2.9% |
| Subdural Haematoma |
2.9% |
| Suicidal Ideation |
2.9% |
| Urge Incontinence |
2.9% |
| Urinary Retention |
2.9% |
| Ventricular Extrasystoles |
2.9% |
|